貨號：GS40685

Suvizumab is a humanized IgG1 kappa monoclonal antibody developed for its anti-HIV-1 activity. It targets a conserved epitope on the HIV-1 envelope glycoprotein (such as gp120 or gp41), neutralizing the virus by blocking viral entry into host cells. It is being investigated as a potential therapeutic or prophylactic agent for HIV-1 infection, particularly in strategies aimed at long-term viral suppression or pre-exposure prevention.